Clinical Trial Update: Open-Label Study of Vaginal AZU-101 in Postmenopausal Women [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2 study evaluating vaginal AZU-101 for postmenopausal symptoms in women; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genitourinary Syndrome of Menopause
• Menopause

Drugs mentioned

• AZU-101

Snippet

Sponsor: Azure Biotech Inc. | Conditions: Postmenopausal Symptoms | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING